S
Seqker Biosciences develops personalized cancer treatments and diagnostics using an integrated intelligent platform for genomic profiling. The company identifies patient-specific neoantigens through genomic analysis of tumor and normal samples to design customized cancer vaccines. This platform also delivers comprehensive genomic profiles to identify actionable drug targets and relevant clinical metrics.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Seqker Biosciences develops personalized cancer treatments and diagnostics using an integrated intelligent platform for genomic profiling. The company identifies patient-specific neoantigens through genomic analysis of tumor and normal samples to design customized cancer vaccines. This platform also delivers comprehensive genomic profiles to identify actionable drug targets and relevant clinical metrics.